Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Peacock

Showing results (41-50 of 135) with videos related to

Pageof 14
Sort By:
Journal of Patient-Reported Outcomes|August 23, 2024
The impact of the COVID-19 pandemic on health-related quality of life of cancer patients in British ColumbiaSara Izadi-Najafabadi, Helen McTaggart-Cowan, Ross Halperin, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment PathwaySara Izadi-Najafabadi, Laurie W Smith, Anna Gottschlich, et al.
Social Science & Medicine (1982)|December 2, 2020
Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regimeFiona A Miller, Pascale Lehoux, Valeria E Rac, et al.
Australia and New Zealand Health Policy|March 10, 2005
Assessing the capacity of the health services research community in Australia and New ZealandJane Pirkis, Sharon Goldfeld, Stuart Peacock, et al.
CMAJ Open|July 29, 2018
Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysisReka Pataky, David A Tran, Andrea Coronado, et al.
The Oncologist|February 4, 2012
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancerLindsay Hedden, Susan O'Reilly, Caroline Lohrisch, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Cancer Patients' Experiences with Telehealth before and during the COVID-19 Pandemic in British ColumbiaSara Izadi-Najafabadi, Lisa McQuarrie, Stuart Peacock, et al.
CMAJ Open|August 1, 2014
Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive studyClaire de Oliveira, Karen E Bremner, Reka Pataky, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 6, 2008
Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study)Vincent H Mabasa, Suzanne Cm Taylor, Christina Cy Chu, et al.
BMC Health Services Research|July 4, 2013
Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national surveyNeale Smith, Craig Mitton, Stirling Bryan, et al.
Pageof 14

Showing results (41-50 of 135) with videos related to

Sort By:
Pageof 14
Journal of Patient-Reported Outcomes|August 23, 2024
The impact of the COVID-19 pandemic on health-related quality of life of cancer patients in British ColumbiaSara Izadi-Najafabadi, Helen McTaggart-Cowan, Ross Halperin, et al.
Current Oncology (Toronto, Ont.)|July 25, 2025
Cervical Cancer Screening Cascade: A Framework for Monitoring Uptake and Retention Along the Screening and Treatment PathwaySara Izadi-Najafabadi, Laurie W Smith, Anna Gottschlich, et al.
Social Science & Medicine (1982)|December 2, 2020
Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regimeFiona A Miller, Pascale Lehoux, Valeria E Rac, et al.
Australia and New Zealand Health Policy|March 10, 2005
Assessing the capacity of the health services research community in Australia and New ZealandJane Pirkis, Sharon Goldfeld, Stuart Peacock, et al.
CMAJ Open|July 29, 2018
Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysisReka Pataky, David A Tran, Andrea Coronado, et al.
The Oncologist|February 4, 2012
Assessing the real-world cost-effectiveness of adjuvant trastuzumab in HER-2/neu positive breast cancerLindsay Hedden, Susan O'Reilly, Caroline Lohrisch, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
Cancer Patients' Experiences with Telehealth before and during the COVID-19 Pandemic in British ColumbiaSara Izadi-Najafabadi, Lisa McQuarrie, Stuart Peacock, et al.
CMAJ Open|August 1, 2014
Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive studyClaire de Oliveira, Karen E Bremner, Reka Pataky, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 6, 2008
Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study)Vincent H Mabasa, Suzanne Cm Taylor, Christina Cy Chu, et al.
BMC Health Services Research|July 4, 2013
Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national surveyNeale Smith, Craig Mitton, Stirling Bryan, et al.
Pageof 14